Skip to main content
Top
Published in: Israel Journal of Health Policy Research 1/2015

Open Access 01-12-2015 | Original research article

Family history intake: a challenge to personalized approaches in health promotion and disease prevention

Authors: Ronit Endevelt, Iris Goren, Tal Sela, Varda Shalev

Published in: Israel Journal of Health Policy Research | Issue 1/2015

Login to get access

Abstract

Background

Family history is considered an essential, obligatory part of the primary physician’s intake interview. Including coded FH in a unified medical file can save expensive genetic tests and detect the early onset of diseases in young people who are not recommended to be screened routinely. The objectives of this study are to explore the frequency and point in time of recording the coded family history (FH) as a first step to increasing awareness of the importance of such information.

Methods

All ICD-9 coded diagnoses of familial histories of disease (ICD-9 coded V16.0 – V19.8), including diseases related to gender, age, and indications of chronic diseases, were collected from the electronic medical records of patients ages 18 and above in Israel’s Maccabi Health Care system. The study was carried out in 2012 on the basis of coded data for 1.9 million Maccabi members, which were collected from 2004 through 2011.

Results

Of the Maccabi members (the second biggest HMO in Israel covering 2 million people), only 10 % had FH coded documentation. FH was significantly more frequent for females than for males (13.5 % vise 10.1 %) and increased with age. About 10 % of the FH documentation occurred before any disease was diagnosed. The most frequent FH documentation was observed for cardiovascular disease, hypertension, and diabetes. In the case of cancer FH was more frequent in females, whereas in the case of males it was cardiovascular disease.

Discussion

Family history is an easy tool and need to be coded and implimented in most visits in order to get the best information of the potential health and disease of the patients.

Conclusions

FH frequency is very low and varies with gender and age. The literature suggests that implementing it routinely in primary care will improve health care. Further research is needed to identify the factors that impede primary care givers from complying with FH guidelines.
Literature
1.
go back to reference Khoury MJ, Coates RJ, Evans JP. Evidence based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidence. Genet Med. 2010;12:680–3.CrossRefPubMed Khoury MJ, Coates RJ, Evans JP. Evidence based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidence. Genet Med. 2010;12:680–3.CrossRefPubMed
2.
go back to reference Acton RT, Burst NM, Casebeer L, Ferguson SM, Greene P, Laird BL, et al. Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics. Acad Med. 2000;75(8):850-2. Acton RT, Burst NM, Casebeer L, Ferguson SM, Greene P, Laird BL, et al. Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics. Acad Med. 2000;75(8):850-2.
3.
4.
go back to reference Summerton N, Garrood PVA. The family history in family practice: a questionnaire study. Fam Pract. 1997;14:285–8.CrossRefPubMed Summerton N, Garrood PVA. The family history in family practice: a questionnaire study. Fam Pract. 1997;14:285–8.CrossRefPubMed
5.
go back to reference Acheson LS, Wiesner GL, Zyzanski SJ, Goodwin MA, Stange KC. Family history-taking in community family practice: implications for genetic screening. Genet Med. 2000;3:180–5.CrossRef Acheson LS, Wiesner GL, Zyzanski SJ, Goodwin MA, Stange KC. Family history-taking in community family practice: implications for genetic screening. Genet Med. 2000;3:180–5.CrossRef
6.
go back to reference Murff HJ, Greevy RA, Syngal S. The comprehensiveness of family cancer history assessments in primary care. Community Genet. 2007;10(3):174–80.CrossRefPubMed Murff HJ, Greevy RA, Syngal S. The comprehensiveness of family cancer history assessments in primary care. Community Genet. 2007;10(3):174–80.CrossRefPubMed
7.
go back to reference Sifri RD, Wender R, Paynter N. Cancer risk assessment from family history: gaps in primary care practice. J Fam Pract. 2002;51:856.PubMed Sifri RD, Wender R, Paynter N. Cancer risk assessment from family history: gaps in primary care practice. J Fam Pract. 2002;51:856.PubMed
8.
go back to reference Sweet KM, Bradley TL, Westman JA. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol. 2002;20(2):528–37.CrossRefPubMed Sweet KM, Bradley TL, Westman JA. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol. 2002;20(2):528–37.CrossRefPubMed
9.
go back to reference Yu J, Goldshtein I, Shalev V, Chodick G, Ish-Shalom S, Sharon O, et al. Association of gastrointestinal events and osteoporosis treatment initiation in newly diagnosed osteoporotic Israeli women. Int J Clin Pract. 2015;69(9):1007–14.CrossRefPubMed Yu J, Goldshtein I, Shalev V, Chodick G, Ish-Shalom S, Sharon O, et al. Association of gastrointestinal events and osteoporosis treatment initiation in newly diagnosed osteoporotic Israeli women. Int J Clin Pract. 2015;69(9):1007–14.CrossRefPubMed
10.
go back to reference Sella T, Goren I, Shalev V, Shapira H, Zandbank J, Rosenblum J, et al. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006–11. Br J Dermatol. 2015;172(1):202–7.CrossRefPubMed Sella T, Goren I, Shalev V, Shapira H, Zandbank J, Rosenblum J, et al. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006–11. Br J Dermatol. 2015;172(1):202–7.CrossRefPubMed
11.
go back to reference Dar L, Shalev V, Weitzman D, Chodick G, Arnson Y, Amital H. No male predominance in offspring of women with rheumatoid arthritis or systemic lupus erythematosus. Immunol Res. 2014;60(2–3):361–5.CrossRefPubMed Dar L, Shalev V, Weitzman D, Chodick G, Arnson Y, Amital H. No male predominance in offspring of women with rheumatoid arthritis or systemic lupus erythematosus. Immunol Res. 2014;60(2–3):361–5.CrossRefPubMed
12.
go back to reference Chodick G, Amital H, Shalem Y, Kokia E, Heymann AD, Porath A, et al. Persistence with statins and onset of rheumatoid arthritis: a population-based cohort stud. PLoS Med. 2010;7:e1000336.PubMedCentralCrossRefPubMed Chodick G, Amital H, Shalem Y, Kokia E, Heymann AD, Porath A, et al. Persistence with statins and onset of rheumatoid arthritis: a population-based cohort stud. PLoS Med. 2010;7:e1000336.PubMedCentralCrossRefPubMed
15.
go back to reference Wang C, Sen A, Ruffin MT, Nease DE, Gramling R, Acheson LS, et al. Family History Assessment Impact on Disease Risk Perceptions. Am J Prev Med. 2012;43(4):392–8.PubMedCentralCrossRefPubMed Wang C, Sen A, Ruffin MT, Nease DE, Gramling R, Acheson LS, et al. Family History Assessment Impact on Disease Risk Perceptions. Am J Prev Med. 2012;43(4):392–8.PubMedCentralCrossRefPubMed
16.
go back to reference Doerr M, Teng K. Family history: still relevant in the genomics era. Cleve Clin J Med. 2012;79(5):331–6.CrossRefPubMed Doerr M, Teng K. Family history: still relevant in the genomics era. Cleve Clin J Med. 2012;79(5):331–6.CrossRefPubMed
17.
go back to reference Wood ME, Flynn BS, Stockdale A. Primary care physician management, referral, and relations with specialists concerning patients at risk for cancer due to family history. Public Health Genomics. 2013;16(3):75–82.CrossRefPubMed Wood ME, Flynn BS, Stockdale A. Primary care physician management, referral, and relations with specialists concerning patients at risk for cancer due to family history. Public Health Genomics. 2013;16(3):75–82.CrossRefPubMed
18.
go back to reference Zazove P, Plegue MA, Uhlmann WR, Ruffin 4th MT. Prompting Primary CareProviders about Increased Patient Risk As a Result of Family History: Does It Work? J Am Board Family Med. 2015;28(3):334–42.CrossRef Zazove P, Plegue MA, Uhlmann WR, Ruffin 4th MT. Prompting Primary CareProviders about Increased Patient Risk As a Result of Family History: Does It Work? J Am Board Family Med. 2015;28(3):334–42.CrossRef
19.
go back to reference Qureshi N, Wilson B, Santaguida P, Carroll J, Allanson J, Culebro CR, et al. Collection and use of cancer family history in primary care. Evidence Report Technology Assessment (Full Rep). (2007) Oct;(159):1–84. Review. Qureshi N, Wilson B, Santaguida P, Carroll J, Allanson J, Culebro CR, et al. Collection and use of cancer family history in primary care. Evidence Report Technology Assessment (Full Rep). (2007) Oct;(159):1–84. Review.
20.
go back to reference Das M, Pal S, Ghosh A. Family history of type 2 diabetes and prevalence of metabolic syndrome in adult Asian Indians. J Cardiovasc Dis Res. 2012;3(2):104–8.PubMedCentralCrossRefPubMed Das M, Pal S, Ghosh A. Family history of type 2 diabetes and prevalence of metabolic syndrome in adult Asian Indians. J Cardiovasc Dis Res. 2012;3(2):104–8.PubMedCentralCrossRefPubMed
21.
go back to reference Qureshi N, Wilson B, Santaguida P. Collection and Use of Cancer Family History in Primary Care. Evidence Report/Technology Assessment No. 159. Evid Rep Technol Assess (Full Rep). 2007 Oct;(159):1–84. Qureshi N, Wilson B, Santaguida P. Collection and Use of Cancer Family History in Primary Care. Evidence Report/Technology Assessment No. 159. Evid Rep Technol Assess (Full Rep). 2007 Oct;(159):1–84.
22.
go back to reference Wood ME, Stockdale A, Flynn BS. Interviews with primary care physicians regarding taking and interpreting the cancer family history. Fam Pract. 2008;25(5):334–40.PubMedCentralCrossRefPubMed Wood ME, Stockdale A, Flynn BS. Interviews with primary care physicians regarding taking and interpreting the cancer family history. Fam Pract. 2008;25(5):334–40.PubMedCentralCrossRefPubMed
24.
go back to reference National Center for Health and Clinical Excellence. Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. London, England: National Collaborating Centre for Primary Care; October, 2006. NICE clinical guideline 41. http://www.nice.org.uk/CG041. Accessed May 2014. National Center for Health and Clinical Excellence. Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. London, England: National Collaborating Centre for Primary Care; October, 2006. NICE clinical guideline 41. http://​www.​nice.​org.​uk/​CG041. Accessed May 2014.
26.
go back to reference US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005;143(5):355–61.CrossRef US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005;143(5):355–61.CrossRef
28.
go back to reference Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, et al. The GRAIDS Trial: a cluster randomized controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer. 2007;97(4):486–93.PubMedCentralCrossRefPubMed Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, et al. The GRAIDS Trial: a cluster randomized controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer. 2007;97(4):486–93.PubMedCentralCrossRefPubMed
29.
go back to reference Acheson LS. Recording, Interpreting, and Updating the Family History of Cancer Implications for Cancer Prevention. JAMA. 2011;306(2):208–10.CrossRefPubMed Acheson LS. Recording, Interpreting, and Updating the Family History of Cancer Implications for Cancer Prevention. JAMA. 2011;306(2):208–10.CrossRefPubMed
30.
go back to reference Hall JA, Roter DL. Patient gender and communication with physicians: Results of a community-based study. Women’s Health. 1995;1:77.PubMed Hall JA, Roter DL. Patient gender and communication with physicians: Results of a community-based study. Women’s Health. 1995;1:77.PubMed
Metadata
Title
Family history intake: a challenge to personalized approaches in health promotion and disease prevention
Authors
Ronit Endevelt
Iris Goren
Tal Sela
Varda Shalev
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Israel Journal of Health Policy Research / Issue 1/2015
Electronic ISSN: 2045-4015
DOI
https://doi.org/10.1186/s13584-015-0055-2

Other articles of this Issue 1/2015

Israel Journal of Health Policy Research 1/2015 Go to the issue